Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Systemic Inflammation in Hemodialysis
NCT00293202Phase 2Terminated
- Start
- Jan 2005
- Primary completion
- Mar 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in end stage renal disease (ESRD). Started Jan 2005; status: terminated.
02
Drugs
etanercept
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00293202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293202.